These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24424441)

  • 1. Non-feminizing estrogens: a novel neuroprotective therapy.
    Petrone AB; Gatson JW; Simpkins JW; Reed MN
    Mol Cell Endocrinol; 2014 May; 389(1-2):40-7. PubMed ID: 24424441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism of non-feminizing estrogens in neuroprotection.
    Engler-Chiurazzi EB; Covey DF; Simpkins JW
    Exp Gerontol; 2017 Aug; 94():99-102. PubMed ID: 27818250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of non-feminizing estrogens for use in neuroprotection.
    Yi KD; Perez E; Yang S; Liu R; Covey DF; Simpkins JW
    Brain Res; 2011 Mar; 1379():61-70. PubMed ID: 21111714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
    Correia SC; Santos RX; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Curr Aging Sci; 2010 Jul; 3(2):113-26. PubMed ID: 20167003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
    Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection and estrogen receptors.
    Simpkins JW; Singh M; Brock C; Etgen AM
    Neuroendocrinology; 2012; 96(2):119-30. PubMed ID: 22538356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.
    Simpkins JW; Richardson TE; Yi KD; Perez E; Covey DF
    Horm Behav; 2013 Feb; 63(2):278-83. PubMed ID: 22498694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanisms for estrogen-induced neuroprotection.
    Singh M; Dykens JA; Simpkins JW
    Exp Biol Med (Maywood); 2006 May; 231(5):514-21. PubMed ID: 16636299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection.
    Marin R; Guerra B; Alonso R; Ramírez CM; Díaz M
    Curr Neurovasc Res; 2005 Oct; 2(4):287-301. PubMed ID: 16181121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease.
    Green PS; Simpkins JW
    Ann N Y Acad Sci; 2000; 924():93-8. PubMed ID: 11193809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and neuroprotection in retinal diseases.
    Kumar DM; Simpkins JW; Agarwal N
    Mol Vis; 2008 Aug; 14():1480-6. PubMed ID: 18698377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial mechanisms of estrogen neuroprotection.
    Simpkins JW; Dykens JA
    Brain Res Rev; 2008 Mar; 57(2):421-30. PubMed ID: 17512984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease.
    Sato K; Takayama KI; Inoue S
    Front Endocrinol (Lausanne); 2023; 14():1220150. PubMed ID: 37469978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.
    Prokai L; Simpkins JW
    Pharmacol Ther; 2007 Apr; 114(1):1-12. PubMed ID: 17336390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective activities of estrogen: an update.
    Behl C; Manthey D
    J Neurocytol; 2000; 29(5-6):351-8. PubMed ID: 11424951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen, cognition and female ageing.
    Genazzani AR; Pluchino N; Luisi S; Luisi M
    Hum Reprod Update; 2007; 13(2):175-87. PubMed ID: 17135285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology.
    Simpkins JW; Wen Y; Perez E; Yang S; Wang X
    Ann N Y Acad Sci; 2005 Jun; 1052():233-42. PubMed ID: 16024766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies.
    Simpkins JW; Yang SH; Wen Y; Singh M
    Cell Mol Life Sci; 2005 Feb; 62(3):271-80. PubMed ID: 15723163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than a decade of estrogen neuroprotection.
    Simpkins JW; Singh M
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S131-6. PubMed ID: 18631989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.